Hrt Financial LP Chroma Dex Corp. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.36 - $3.84 $160,810 - $454,053	118,243 Added 938.29%	130,845 $455,000
Q4 2023 Feb 09, 2024	BUY	$1.28 - $1.6 $16,130 - $20,163	12,602 New	12,602 $18,000
Q2 2023 Aug 11, 2023	BUY	$1.31 - $1.79 $23,245 - $31,763	17,745 New	17,745 $27,000
Q2 2022 Aug 12, 2022	BUY	$1.59 - $2.7 $60,081 - $102,024	37,787 New	37,787 $63,000
Q4 2020 Feb 16, 2021	SELL	$3.93 - $5.5 $41,559 - $58,162	-10,575 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.01 - $5.56 $42,405 - $58,796	10,575 New	10,575 $42,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $510M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.